‍

Apply for the Merck 2020 European Advance Biotech Grant Program and win €240.000 to accelerate your molecule to clinic faster.
Your promising molecule requires resources and support to realize it’s potential. MVA-member, Merck, is accepting applications till March 1st, 2020 for a chance to win Merck’s Bioprocessing /Actives and Formulation product portfolio and consultation.  (Excludes BioReliance® services.)
Learn more and submit a completed application before 1st March 2020. The grant winner will be announced in April 2020.

For more information please contact:

Melissa Nackovski
Sales Development Specialist Emerging Biotech – Nordics
Life Science | Process Solutions
Merck Chemicals & Lifescience AB | Box 3033 | 16903 Solna | Sweden

Mobile Phone: +46 723 62 6331
E-mail: melissa.nackovski@merckgroup.com
www.merckmillipore.com/emergingbiotech

The post Merck 2020 European Advance Biotech Grant Program – Win €240.000 to Accelerate your Molecule to Clinic faster appeared first on MVA.

‍